LEADER SPOTLIGHT
Andrzej Bialkowski-Miler
Chief Executive Officer
“We are dedicated to advancing interventional cardiology through innovative access site closure devices. Our teams, tools, and technologies support our R&D strategy to create value-added solutions that improve patient outcomes and reduce costs with novel closure and monitoring technologies."
Aligning science and experience to improve interventional cardiology outcomes
Andrzej Bialkowski-Miler
Chief Executive Officer
Mariusz Kruk, MD, PhD, Professor of Medicine
Chief Medical Officer
Emilia Lembryk
Regulatory Affairs Manager
Werner Deichmann
Chief IP Counsel
Miroslaw Baszun
Chief Engineer
Marzena Zawadzka
Business Development Manager
Patrycja Platek
Compliance ManagerAdvisory Board
Jan Skowroński, MD
Medical Advisor